Acné – 2001

Acne Vulgaris – 2001

FDA, Roche to implement new dispensing procedures for isotretinoin.

Young D.

Am J Health Syst Pharm. 2001 Dec 15;58(24):2359-60.

Concentration of roxithromycin in the lesions of acne vulgaris.

Akamatsu H, Horio T.

J Int Med Res. 2001 Nov-Dec;29(6):537-40.

Clinical significance of markedly elevated serum creatine kinase levels in patients with acne on isotretinoin.

Landau M, Mesterman R, Ophir J, Mevorah B, Alcalay J, Harel A, Nevo Y.

Acta Derm Venereol. 2001 Oct-Nov;81(5):350-2.

Prevention and treatment of side effects and complications of cutaneous laser resurfacing.

Alster TS, Lupton JR.

Plast Reconstr Surg. 2002 Jan;109(1):308-16; discussion 317-8. Review.

[Acne inversa in Crohn’s disease].

Goischke HK, Ochsendorf FR.

Z Gastroenterol. 2001 Nov;39(11):965-9. German.

Aminolevulinic acid: pharmacological profile and clinical indication.

Lang K, Lehmann P, Bolsen K, Ruzicka T, Fritsch C.

Expert Opin Investig Drugs. 2001 Jun;10(6):1139-56. Review.

[Comparative study of the efficacy and tolerance of 12% glycolic acid cream and 0.05% retinoic acid cream for polymorphic acne].

Kharfi M, Tekaya N, Zeglaoui F, Ezzine N, Mokhtar I, Kamoun F, Kamoun MR.

Tunis Med. 2001 Jun-Jul;79(6-7):374-7. French.

[Tetracycline treatment, oral contraceptives and pregnancy].

Hedegaard FU, Damkier P.

Ugeskr Laeger. 2001 Nov 19;163(47):6567. Danish.

Rashes in infants. Pitfalls and masquerades.

Orchard D.

Aust Fam Physician. 2001 Nov;30(11):1047-51. Review.

Patient education sheet. How common is acne?

Clearihan L.

Aust Fam Physician. 2001 Nov;30(11):1045.

Acne. Myths and management issues.

Clearihan L.

Aust Fam Physician. 2001 Nov;30(11):1039-44. Review.

Is acne vulgaris a genuine inflammatory disease?

Zouboulis CC.

Dermatology. 2001;203(4):277-9.

Detection of transposon Tn5432-mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities.

Ross JI, Eady EA, Carnegie E, Cove JH.

J Antimicrob Chemother. 2002 Jan;49(1):165-8.

Treatment of acne vulgaris and prevention of acne scarring: canadian consensus guidelines.

Madden WS, Landells ID, Poulin Y, Searles GE, Smith KC, Tan JK, Toole J, Zip CM, Degreef H.

J Cutan Med Surg. 2000 Jun;4 Suppl 1:S2-13.

Dyslipidemia and a reversible decrease in insulin sensitivity induced by therapy with 13-cis-retinoic acid.

Koistinen HA, Remitz A, Gylling H, Miettinen TA, Koivisto VA, Ebeling P.

Diabetes Metab Res Rev. 2001 Sep-Oct;17(5):391-5.

Acne in Becker’s nevus.

Agrawal S, Garg VK, Sah SP, Agarwalla A.

Int J Dermatol. 2001 Sep;40(9):583-5.

Scar revision via resurfacing.

Bradley DT, Park SS.

Facial Plast Surg. 2001 Nov;17(4):253-62. Review.

Interstitial nephritis, hepatic failure, and systemic eosinophilia after minocycline treatment.

Kiessling S, Forrest K, Moscow J, Gewirtz A, Jackson E, Roszman T, Goebel J.

Am J Kidney Dis. 2001 Dec;38(6):E36.

[SAPHO syndrome–results of 2-phase bone scintigraphy].

Höpfner S, Partscht K, Dresel S, Hahn K.

Nuklearmedizin. 2001 Oct;40(5):N48-50. German.

Regarding the study on microdermabrasion for acne.

Palmer GD.

Dermatol Surg. 2001 Oct;27(10):914.

The trauma of acne.

[No authors listed]

Arch Dis Child. 2001 Dec;85(6):491.

[Acne inversa: a dapsone-sensitive dermatosis].

Hofer T, Itin PH.

Hautarzt. 2001 Oct;52(10 Pt 2):989-92. German.

The effect of the menstrual cycle on acne.

Stoll S, Shalita AR, Webster GF, Kaplan R, Danesh S, Penstein A.

J Am Acad Dermatol. 2001 Dec;45(6):957-60.

Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions.

Chronnell CM, Ghali LR, Ali RS, Quinn AG, Holland DB, Bull JJ, Cunliffe WJ, McKay IA, Philpott MP, Müller-Röver S.

J Invest Dermatol. 2001 Nov;117(5):1120-5.

Optimal management of acne to prevent scarring and psychological sequelae.

Layton AM.

Am J Clin Dermatol. 2001;2(3):135-41. Review.

Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris.

Leyden JJ, Berger RS, Dunlap FE, Ellis CN, Connolly MA, Levy SF.

Am J Clin Dermatol. 2001;2(1):33-9.

Is acne an infection of blocked pilosebaceous follicles? Implications for antimicrobial treatment.

Eady EA, Cove JH.

Am J Clin Dermatol. 2000 Jul-Aug;1(4):201-9. Review.

alpha-Hydroxy acid-based cosmetic procedures. Guidelines for patient management.

Tung RC, Bergfeld WF, Vidimos AT, Remzi BK.

Am J Clin Dermatol. 2000 Mar-Apr;1(2):81-8. Review.

Management of post-acne scarring. What are the options for treatment?

Goodman GJ.

Am J Clin Dermatol. 2000 Jan-Feb;1(1):3-17. Review.

Acne excoriata–look for allergy!

Kränke B, Brabek E, Derhaschnig J, Aberer W.

Dermatology. 2001;203(3):256-7.

Erythromycin-resistance of cutaneous bacterial flora in acne.

Dreno B, Reynaud A, Moyse D, Habert H, Richet H.

Eur J Dermatol. 2001 Nov-Dec;11(6):549-53.

Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.

Gollnick HP, Graupe K, Zaumseil RP.

Eur J Dermatol. 2001 Nov-Dec;11(6):538-44.

Preparation and comparative clinical evaluation of liposomal gel of benzoyl peroxide for acne.

Patel VB, Misra AN, Marfatia YS.

Drug Dev Ind Pharm. 2001 Sep;27(8):863-9.

Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.

Farquhar C, Lee O, Toomath R, Jepson R.

Cochrane Database Syst Rev. 2001;(4):CD000194. Review. Update in: Cochrane Database Syst Rev. 2003;(4):CD000194.

[Pseudotumor cerebri in minocyline treatment].

Oswald J, Meier K, Reinhart WH, Kuhn M.

Praxis (Bern 1994). 2001 Sep 27;90(39):1691-3. German.

Isotretinoin-induced inflammatory bowel disease in an adolescent.

Reniers DE, Howard JM.

Ann Pharmacother. 2001 Oct;35(10):1214-6.

Adverse effects of isotretinoin therapy for acne vulgaris.

Lamb SR, Oakley AM.

N Z Med J. 2001 Sep 14;114(1139):414.

Analysis of common side effects of isotretinoin.

McLane J.

J Am Acad Dermatol. 2001 Nov;45(5):S188-94. Review.

Isotretinoin effects on bone.

DiGiovanna JJ.

J Am Acad Dermatol. 2001 Nov;45(5):S176-82. Review.

Suicide, depression, and isotretinoin: is there a causal link?

Jacobs DG, Deutsch NL, Brewer M.

J Am Acad Dermatol. 2001 Nov;45(5):S168-75. Review.

Uses and complications of isotretinoin therapy.

Ellis CN, Krach KJ.

J Am Acad Dermatol. 2001 Nov;45(5):S150-7. Review.

Interaction of isotretinoin with endogenous retinoids.

Törmä H.

J Am Acad Dermatol. 2001 Nov;45(5):S143-9. Review.

Minocycline, perinuclear antineutrophilic cytoplasmic antibody, and pigment: the biochemical basis.

Shapiro LE, Uetrecht J, Shear NH.

J Am Acad Dermatol. 2001 Nov;45(5):787-9.

Potential therapeutic effects of prescribed and over-the-counter androgens in women.

Khorram O.

Clin Obstet Gynecol. 2001 Dec;44(4):880-92. Review.

Complications of chemical resurfacing.

Brody HJ.

Dermatol Clin. 2001 Jul;19(3):427-38, vii-viii. Review.

Cosmetics in acne and rosacea.

Draelos ZD.

Semin Cutan Med Surg. 2001 Sep;20(3):209-14. Review.

Treatment of acne scarring.

Hirsch RJ, Lewis AB.

Semin Cutan Med Surg. 2001 Sep;20(3):190-8. Review.

Acne therapy: clinical pearls.

Stein RH, Lebwohl M.

Semin Cutan Med Surg. 2001 Sep;20(3):184-9. Review.

Safety issues in isotretinoin therapy.

Hanson N, Leachman S.

Semin Cutan Med Surg. 2001 Sep;20(3):166-83. Review.

Isotretinoin dosing: past, present, and future trends.

Hirsch RJ, Shalita AR.

Semin Cutan Med Surg. 2001 Sep;20(3):162-5. Review. Erratum in: Semin Cutan Med Surg 2002 Mar;21(1):104.

Developments in topical retinoid therapy for acne.

Bershad S.

Semin Cutan Med Surg. 2001 Sep;20(3):154-61. Review.

Hormones and acne: pathophysiology, clinical evaluation, and therapies.

Thiboutot D.

Semin Cutan Med Surg. 2001 Sep;20(3):144-53. Review.

The evolving role of Propionibacterium acnes in acne.

Leyden JJ.

Semin Cutan Med Surg. 2001 Sep;20(3):139-43. Review.

Acne. Introduction.

Thiboutot D.

Semin Cutan Med Surg. 2001 Sep;20(3):137-8.

Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris.

Dreno B, Moyse D, Alirezai M, Amblard P, Auffret N, Beylot C, Bodokh I, Chivot M, Daniel F, Humbert P, Meynadier J, Poli F; Acne Research and Study Group.

Dermatology. 2001;203(2):135-40.

Psychosocial impact of acne vulgaris. evaluation of the relation between a change in clinical acne severity and psychosocial state.

Mulder MM, Sigurdsson V, van Zuuren EJ, Klaassen EJ, Faber JA, de Wit JB, van Vloten WA.

Dermatology. 2001;203(2):124-30.

Clinical trials of ayurvedic formulations in the treatment of acne vulgaris.

Lalla JK, Nandedkar SY, Paranjape MH, Talreja NB.

J Ethnopharmacol. 2001 Nov;78(1):99-102.

Minocycline hypersensitivity syndrome with hypotension mimicking septic shock.

Colvin JH, Sheth AP.

Pediatr Dermatol. 2001 Jul-Aug;18(4):295-8.

[Dermatologic aspects of SAPHO-syndrome].

Károlyi Z, Harhai I, Erós N.

Orv Hetil. 2001 Aug 19;142(33):1801-4. Hungarian.

Acne vulgaris: update on therapy.

Quirk CM.

Med Health R I. 2001 Sep;84(9):296-8.

Persistent acne in adult women.

Shaw JC, White LE.

Arch Dermatol. 2001 Sep;137(9):1252-3.

Propionibacterium acnes: an indigenous bacterium may be pathogenic in several cutaneous disease states.

Burkhart CG, Burkhart CN.

Arch Dermatol. 2001 Sep;137(9):1250.

Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon).

Worret I, Arp W, Zahradnik HP, Andreas JO, Binder N.

Dermatology. 2001;203(1):38-44.

Rosacea and adult acne: a worldwide epidemic.

Silverberg NB, Weinberg JM.

Cutis. 2001 Aug;68(2):85.

A clinical and therapeutic study of 29 patients with infantile acne.

Cunliffe WJ, Baron SE, Coulson IH.

Br J Dermatol. 2001 Sep;145(3):463-6.

Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community-based study.

Smithard A, Glazebrook C, Williams HC.

Br J Dermatol. 2001 Aug;145(2):274-9.

[Impact of the impaired intestinal microflora on the course of acne vulgaris].

Volkova LA, Khalif IL, Kabanova IN.

Klin Med (Mosk). 2001;79(6):39-41. Russian.

[“Cleansing, topical treatment, oral administration”. Controlling acne].

Koczorek M.

MMW Fortschr Med. 2001 Jul 26;143(30):12-3. German.

A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany.

Vree ML, Schmidt J.

Eur J Contracept Reprod Health Care. 2001 Jun;6(2):108-14.

Continued occurrence of Accutane-exposed pregnancies.

Honein MA, Paulozzi LJ, Erickson JD.

Teratology. 2001 Sep;64(3):142-7.

The modern age of acne therapy: a review of current treatment options.

Bershad SV.

Mt Sinai J Med. 2001 Sep-Oct;68(4-5):279-86. Review.

[Therapies for infections diseases in the 21st century. The role of minocycline among common treatments–focused on oral formulations(discussion)].

Matsushima T, Arakawa S, Honda M, Shiba T.

Jpn J Antibiot. 2001 May;54(5):179-84. Japanese.

Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial.

Webster GF, Berson D, Stein LF, Fivenson DP, Tanghetti EA, Ling M.

Cutis. 2001 Jun;67(6 Suppl):4-9.

Randomized facial tolerability studies comparing gel formulations of retinoids used to treat acne vulgaris.

Leyden J, Grove GL.

Cutis. 2001 Jun;67(6 Suppl):17-27.

Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial.

Leyden J, Lowe N, Kakita L, Draelos Z.

Cutis. 2001 Jun;67(6 Suppl):10-6.

Isotretinoin (roaccutane) usage–a South African consensus guideline. National Dermatology Working Group.

[No authors listed]

S Afr Med J. 1997 Oct;87(10 Pt 2):1410-3. Review.

Minocycline and Pseudotumor cerebri: The well-known but well-kept secret.

Weese-Mayer DE, Yang RJ, Mayer JR, Zaparackas Z.

Pediatrics. 2001 Aug;108(2):519-20.

Health-related quality of life among patients with facial acne — assessment of a new acne-specific questionnaire.

Martin AR, Lookingbill DP, Botek A, Light J, Thiboutot D, Girman CJ.

Clin Exp Dermatol. 2001 Jul;26(5):380-5.

Polycythemia in a patient treated with isotretinoin.

Cakmakci A, Yilmaz AS, Akbulut S, Gül U, Ozyilkan E.

Ann Pharmacother. 2001 Jul-Aug;35(7-8):964-5.

Severe acne with lithium.

Oztas P, Aksakal AB, Oztas MO, Onder M.

Ann Pharmacother. 2001 Jul-Aug;35(7-8):961-2.

From vitamin to Vesanoid: systemic retinoids for the new millennium.

Kerr PE, DiGiovanna JJ.

Med Health R I. 2001 Jul;84(7):228-31.

Scars: the battle over isotretinoin.

Weinberg JM.

Cutis. 2001 Jul;68(1):18.

Pathogenesis of acne.

Toyoda M, Morohashi M.

Med Electron Microsc. 2001 Mar;34(1):29-40. Review.

The psychological comorbidity in acne.

Gupta MA, Gupta AK.

Clin Dermatol. 2001 May-Jun;19(3):360-3. Review.

[Acne. Diagnosis, physiopathology and treatment].

[No authors listed]

Ann Dermatol Venereol. 2000 Oct;127(Spec No 1):A186-91. French.

Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.

Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, Lowe NJ, Jones TM, Stewart DM, Jarratt MT, Katz I, Pariser DM, Pariser RJ, Tschen E, Chalker DK, Rafal ES, Savin RP, Roth HL, Chang LK, Baginski DJ, Kempers S, McLane J, Eberhardt D, Leach EE, Bryce G, Hong J.

J Am Acad Dermatol. 2001 Aug;45(2):196-207.

A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne.

Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, Lowe NJ, Jones TM, Stewart DM, Jarratt MT, Katz I, Pariser DM, Pariser RJ, Tschen E, Chalker DK, Rafal ES, Savin RP, Roth HL, Chang LK, Baginski DJ, Kempers S, McLane J, Eberhardt D, Leach EE, Bryce G, Hong J.

J Am Acad Dermatol. 2001 Aug;45(2):187-95.

Microdermabrasion.

Freeman MS.

Facial Plast Surg Clin North Am. 2001 May;9(2):257-66, viii.

Epidemiology of acne in the general population: the risk of smoking.

Schäfer T, Nienhaus A, Vieluf D, Berger J, Ring J.

Br J Dermatol. 2001 Jul;145(1):100-4.

Lipid analysis of follicular casts from cyanoacrylate strips as a new method for studying therapeutic effects of antiacne agents.

Thielitz A, Helmdach M, Röpke EM, Gollnick H.

Br J Dermatol. 2001 Jul;145(1):19-27.

[Acne. The molecular action of androgens].

Sultan C, Poujol N, Gobinet J.

Ann Dermatol Venereol. 2001 Apr;128 Supp 1:S7-9. French.

[Acne. Introduction: which methods for what new treatments?].

Daniel F.

Ann Dermatol Venereol. 2001 Apr;128 Supp 1:S5-6. French.

[Acne. Is isotretinoin pro- or anti-inflammatory?].

Berbis P.

Ann Dermatol Venereol. 2001 Apr;128 Supp 1:S25-8; discussion S33. Review. French.

[What is the role of hormonal treatments in acne?].

Drapier-Faure E, Faure M.

Ann Dermatol Venereol. 2001 Apr;128 Supp 1:S19-24; discussion S33. Review. French.

[What to think about bacterial resistances in acne?].

Richet H, Andre-Richet B, Gallou FL.

Ann Dermatol Venereol. 2001 Apr;128 Supp 1:S15-7; discussion S31-2. Review. French.

[Are androgens responsible for comedone formation?].

Meynadier J.

Ann Dermatol Venereol. 2001 Apr;128 Supp 1:S11-3; discussion S29. Review. French.

The effects of Silicol Skin on moderate to severe acne: UK field survey.

Acne Support Group.

Adv Ther. 2001 Mar-Apr;18(2):93-9.

Successful removal by ruby laser of darkened ink after ruby laser treatment of mismatched tattoos for acne scars.

Rüdlinger R.

J Cutan Laser Ther. 2000 Mar;2(1):37-9.

The power of Accutane. The benefits and risks of a breakthrough acne drug.

Meadows M.

FDA Consum. 2001 Mar-Apr;35(2):18-23.

Microdermabrasion: a clinical and histopathologic study.

Shim EK, Barnette D, Hughes K, Greenway HT.

Dermatol Surg. 2001 Jun;27(6):524-30.

[Effects of macrolide therapy on patients with acne vulgaris].

Akamatsu H.

Jpn J Antibiot. 2001 Feb;54 Suppl A:109-12. Review. Japanese.

[Minocycline-induced pneumonitis presenting as multiple ring-shaped opacities on chest CT, pathologically diagnosed bronchiolitis obliterans organizing pneumonia (BOOP)].

Kondo H, Fujita J, Inoue T, Horiuchi N, Nakao K, Iwata M, Haba R, Ohtsuki Y.

Nihon Kokyuki Gakkai Zasshi. 2001 Mar;39(3):215-9. Review. Japanese.

[Aggravation of asthma by isotretinoine].

Schmutz JL, Barbaud A, Trechot P.

Ann Dermatol Venereol. 2001 May;128(5):691. French.

[Minocycline].

Bernier C, Dréno B.

Ann Dermatol Venereol. 2001 May;128(5):627-37. Review. French.

Acne scarring: a classification system and review of treatment options.

Jacob CI, Dover JS, Kaminer MS.

J Am Acad Dermatol. 2001 Jul;45(1):109-17. Review.

A double-blind investigation of the potential systemic absorption of isotretinoin, when combined with chemical sunscreens, following topical application to patients with widespread acne of the face and trunk.

Cunliffe WJ, Glass D, Goode K, Stables GI, Boorman GC.

Acta Derm Venereol. 2001 Jan-Feb;81(1):14-7.

Managing adolescent acne.

Krowchuk DP, Lucky AW.

Adolesc Med. 2001 Jun;12(2):vii, 355-74. Review.

The impact of skin disease on the quality of life of adolescents.

Smith JA.

Adolesc Med. 2001 Jun;12(2):vii, 343-53. Review.

Fate of PCDF/PCB congeners and change of clinical symptoms in patients with Yusho PCB poisoning for 30 years.

Masuda Y.

Chemosphere. 2001 May-Jun;43(4-7):925-30.

Minocycline induced lupus: case series in the West of Scotland.

Gordon MM, Porter D.

J Rheumatol. 2001 May;28(5):1004-6.

Modulated dual mode erbium/CO2 lasers for the treatment of acne scars.

Weinstein C.

J Cutan Laser Ther. 1999 Dec;1(4):204-8.

Scanned continuous wave CO2 laser resurfacing: a closer look at the different scanning modes.

Huilgol SC, Poon E, Calonje E, Seed PT, Huilgol RR, Markey AC, Barlow RJ.

Dermatol Surg. 2001 May;27(5):467-70.

Laser resurfacing: a safe and predictable method of skin resurfacing.

Lent WM, David LM.

J Cutan Laser Ther. 1999 Apr;1(2):87-94.

Hereditary glucocorticoid resistance.

Lamberts SW.

Ann Endocrinol (Paris). 2001 Apr;62(2):164-7. Review.

Improvement of acne in depressed patients treated with paroxetine.

Moussavian H.

J Am Acad Child Adolesc Psychiatry. 2001 May;40(5):505-6.

The role of the antioxidative defense system in papulopustular acne.

Basak PY, Gultekin F, Kilinc I.

J Dermatol. 2001 Mar;28(3):123-7.

Hyperandrogenemia in patients presenting with acne.

Slayden SM, Moran C, Sams WM Jr, Boots LR, Azziz R.

Fertil Steril. 2001 May;75(5):889-92.

Preferential prescribing of type of combined oral contraceptive pill by general practitioners to teenagers with acne.

Rowlands S, Devalia H, Lawrenson R.

Eur J Contracept Reprod Health Care. 2001 Mar;6(1):9-13.

Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate.

Vartiainen M, de Gezelle H, Broekmeulen CJ.

Eur J Contracept Reprod Health Care. 2001 Mar;6(1):46-53.

Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?

Cibula D, Hill M, Fanta M, Sindelka G, Zivny J.

Hum Reprod. 2001 May;16(5):940-4.

Laser resurfacing for facial acne scars.

Jordan RE, Cummins CL, Burls AJ, Seukeran DC.

Cochrane Database Syst Rev. 2001;(1):CD001866. Review.

Digital fluorescence as a parameter of Propionibacterium acnes suppression needs assessment.

Burkhart CN.

Int J Dermatol. 2001 Feb;40(2):101-3.

Laser punch-out for acne scars.

Koo SH, Yoon ES, Ahn DS, Park SH.

Aesthetic Plast Surg. 2001 Jan-Feb;25(1):46-51.

[Correlations between acne and polycystic ovary. A study of 60 cases].

Iurassich S, Trotta C, Palagiano A, Pace L.

Minerva Ginecol. 2001 Apr;53(2):107-11. Italian.

[Acne flare-up and deterioration with oral isotretinoin].

Chivot M.

Ann Dermatol Venereol. 2001 Mar;128(3 Pt 1):224-8. French.

Watery eye: a new side-effect of isotretinoin therapy.

Chua WC, Martin PA, Kourt G.

Eye (Lond). 2001 Feb;15(Pt 1):115-6.

Perceptions of acne vulgaris in final year medical student written examination answers.

Green J, Sinclair RD.

Australas J Dermatol. 2001 May;42(2):98-101.

Post-acne scarring: a short review of its pathophysiology.

Goodman GJ.

Australas J Dermatol. 2001 May;42(2):84-90. Review.

A novel treatment for acne vulgaris and rosacea.

Elewski BE.

J Eur Acad Dermatol Venereol. 2000 Sep;14(5):423-4.

The use of microdermabrasion for acne: a pilot study.

Lloyd JR.

Dermatol Surg. 2001 Apr;27(4):329-31.

Isotretinoin use and reports of sustained dreaming.

Gupta MA, Gupta AK.

Br J Dermatol. 2001 Apr;144(4):919-20.

Nasolabial follicular sebaceous casts: a novel complication of isotretinoin therapy.

Plewig G.

Br J Dermatol. 2001 Apr;144(4):919.

Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel.

Queille-Roussel C, Poncet M, Mesaros S, Clucas A, Baker M, Soloff AM.

Clin Ther. 2001 Feb;23(2):205-12.

Acne with chronic recurrent multifocal osteomyelitis involving the mandible as part of the SAPHO syndrome: case report.

Roldán JC, Terheyden H, Dunsche A, Kampen WU, Schroeder JO.

Br J Oral Maxillofac Surg. 2001 Apr;39(2):141-4.

Highly sensitive and specific time-resolved fluoroimmunoassay (TR-FIA) of cyproterone acetate and free cyproterone.

Fiet J, Giton F, Boudi A, Boudou P, Vexiau P, Galons H, Raynaud JP.

J Steroid Biochem Mol Biol. 2000 Dec 31;75(4-5):315-22.

The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product.

Leyden JJ, Hickman JG, Jarratt MT, Stewart DM, Levy SF.

J Cutan Med Surg. 2001 Jan-Feb;5(1):37-42.

Olanzapine may be an effective adjunctive therapy in the management of acne excoriée: a case report.

Gupta MA, Gupta AK.

J Cutan Med Surg. 2001 Jan-Feb;5(1):25-7.

Azithromycin monthly pulse vs daily doxycycline in the treatment of acne vulgaris.

Parsad D, Pandhi R, Nagpal R, Negi KS.

J Dermatol. 2001 Jan;28(1):1-4.

Severe acne as a side effect of propranolol and nadolol in a migraineur.

Bajwa ZH, Sami N, Flory C.

Headache. 1999 Nov-Dec;39(10):758-60.

Elevated plasma homocysteine levels in patients on isotretinoin therapy for cystic acne.

Schulpis KH, Karikas GA, Georgala S, Michas T, Tsakiris S.

Int J Dermatol. 2001 Jan;40(1):33-6.

Hidradenitis suppurativa and acne conglobata associated with spondyloarthropathy.

Leybishkis B, Fasseas P, Ryan KF, Roy R.

Am J Med Sci. 2001 Mar;321(3):195-7.

Doxycycline-induced esophageal ulceration.

Isler M.

Mil Med. 2001 Mar;166(3):203, 222.

Acne of the scalp-why is it so rare?

Gach JE, Humphreys F.

Clin Exp Dermatol. 2001 Jan;26(1):101-2.

Stump acne: a new variant of acne mechanica and a cause of immobility.

Strauss RM, Harrington CI.

Br J Dermatol. 2001 Mar;144(3):647-8.

What is the cumulative effect of long-term, low-dose isotretinoin on the development of DISH?

Ling TC, Parkin G, Islam J, Seukeran DC, Cunliffe WJ.

Br J Dermatol. 2001 Mar;144(3):630-2.

Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients.

Itoh Y, Ninomiya Y, Tajima S, Ishibashi A.

Br J Dermatol. 2001 Mar;144(3):575-9.

Hormonal contraception in the male.

Anderson RA.

Br Med Bull. 2000;56(3):717-28. Review.

Androgen physiology and the cutaneous pilosebaceous unit.

Mercurio MG, Gogstetter DS.

J Gend Specif Med. 2000 May-Jun;3(4):59-64. Review.

Familial dysmorphophobia.

Seaton ED, Baxter KF, Cunliffe WJ.

Br J Dermatol. 2001 Feb;144(2):439-40.

Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.

Ross JI, Snelling AM, Eady EA, Cove JH, Cunliffe WJ, Leyden JJ, Collignon P, Dréno B, Reynaud A, Fluhr J, Oshima S.

Br J Dermatol. 2001 Feb;144(2):339-46.

Antibiotics in acne: time for a rethink.

Simpson N.

Br J Dermatol. 2001 Feb;144(2):225-7.

A quantitative biometrological assessment of acne and hormonal evaluation in young women using a triphasic low-dose oral contraceptive containing gestodene.

Piérard-Franchimont C, Gaspard U, Lacante P, Rhoa M, Slachmuylders P, Piérard GE.

Eur J Contracept Reprod Health Care. 2000 Dec;5(4):275-86.

Effect of a desogestrel-containing oral contraceptive on the skin.

Katz HI, Kempers S, Akin MD, Dunlap F, Whiting D, Norbart TC.

Eur J Contracept Reprod Health Care. 2000 Dec;5(4):248-55.

Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore.

Tan HH, Goh CL, Yeo MG, Tan ML.

Ann Acad Med Singapore. 2001 Jan;30(1):22-5.

Oral contraceptives in the treatment of acne.

Tan JK, Degreef H.

Skin Therapy Lett. 2001 Feb;6(5):1-3.

A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris.

Tschen EH, Katz HI, Jones TM, Monroe EW, Kraus SJ, Connolly MA, Levy SF.

Cutis. 2001 Feb;67(2):165-9.

Dermatopharmacology of a new combination gel formulation for the topical treatment of acne.

Levy S.

Cutis. 2001 Feb;67(2 Suppl):8-12.

Are 2 combined antimicrobial mechanisms better than 1 for the treatment of acne vulgaris? Clinical and antimicrobial results of a topical combination product containing 1% clindamycin and 5% benzoyl peroxide. Introduction.

Leyden J.

Cutis. 2001 Feb;67(2 Suppl):5-7.

Potential role for a new combination topical therapy in treating mild to moderate acne vulgaris.

Tschen E.

Cutis. 2001 Feb;67(2 Suppl):25-7.

Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris.

Ellis CN, Leyden J, Katz HI, Goldfarb MT, Hickman J, Jones TM, Tschen E.

Cutis. 2001 Feb;67(2 Suppl):13-20. Erratum in: Cutis 2001 Mar;67(3):257.

[Prevalence of cutaneous lesions in Freixo de Espada à Cinta].

Massa A, Alves R, Amado J, Matos E, Sanches M, Selores M, Santos C, Costa V, Velho G, Oliveira M, Ferreira E, Taveira M, Silva NS, Granado E, Lemos A, Calheiros JM.

Acta Med Port. 2000 Sep-Dec;13(5-6):247-54. Portuguese.

Oral contraceptives: current status.

Burkman RT.

Clin Obstet Gynecol. 2001 Mar;44(1):62-72. Review.

Minocycline-induced generalized postinflammatory elastolysis.

Ho NC, Levy H, Francomano CA, Elkayam O.

Am J Med. 2000 Sep;109(4):340-1.

Acne chlorina and acne vulgaris–casual likeness or casual homology?

Panteleyev AA, Thiel R, Rosenbach T, Christiano AM.

Arch Dermatol Res. 2000 Nov;292(11):577-81.

[Systemic therapy in acne emergency. When skin erupts].

Reinhold U.

MMW Fortschr Med. 2000 Dec 7;142(49-50):45-6. German.

[Acne neonatorum/acne infantum].

Holm EA, Jemec GB.

Ugeskr Laeger. 2000 Dec 11;162(50):6856-7. Danish.

[Treatment of acne].

Jemec GB.

Ugeskr Laeger. 2000 Dec 11;162(50):6840-4. Review. Danish.

Beliefs and perceptions of patients with acne.

Tan JK, Vasey K, Fung KY.

J Am Acad Dermatol. 2001 Mar;44(3):439-45.

Punch techniques, acne scarring, and resurfacing.

Field LM.

Dermatol Surg. 2001 Feb;27(2):219-20.

Resurfacing of pitted facial acne scars with a long-pulsed Er:YAG laser.

Jeong JT, Kye YC.

Dermatol Surg. 2001 Feb;27(2):107-10.

Isotretinoin use in acne: prospective evaluation of adverse events.

Hull PR, Demkiw-Bartel C.

J Cutan Med Surg. 2000 Apr;4(2):66-70.

Is serum sickness an uncommon adverse effect of minocycline treatment?

Malakar S, Dhar S, Shah Malakar R.

Arch Dermatol. 2001 Jan;137(1):100-1.

Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature.

Green D, Friedman KJ.

J Am Acad Dermatol. 2001 Feb;44(2 Suppl):342-7. Review..

Hormonal therapy in dermatology.

Shaw JC.

Dermatol Clin. 2001 Jan;19(1):169-78, ix. Review.

Systemic retinoid therapy.

DiGiovanna JJ.

Dermatol Clin. 2001 Jan;19(1):161-7. Review.